Slide 1: Where Technology Comes to Life
WHERE TECHNOLOGY COMES TO LIFE Q2 2025
Slide 2: Forward Looking Statement
Forward Looking Statement This presentation contains forward-looking statements within the Israeli Securities Law, 1968, the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws, as amended, regarding Pluri Inc. and/or its subsidiaries (collectively the “Company” o
Slide 3: Pluri Venture Creation
Pluri Venture Creation Company Sectors Partners Regenerative ~$22 million (as of Medicine December 31, 2024) Cultivated Meat ~ Contract Development and Manufacturing Organization Cell-Based Agriculture
Slide 4: From Single Cells To Sustainable Solutions
From Single Cells To Sustainable Solutions Pluri harnesses the power of cells, the building blocks of life, to deliver eco-friendly solutions that aim to enhance individual well-being and drive positive global change Pluri leverages two decades of experience and proprietary platform for cell-based s
Slide 5: Eight Billion Lives. One Planet. Zero Time to Waste.
Eight Billion Lives. One Planet. Zero Time to Waste. Aging and Health Climate Change Food Security Sustainability A growing, aging world urgently needs scalable, sustainable solutions
Slide 6: Pluri Technological Platform
Pluri Technological Platform Innovative Validated
Slide 7: Bio-Farming: Industrial Scale Production
Bio-Farming: Industrial Scale Production PluriMatrix™
Slide 8: Cell-based Technology Platform
Cultivated cacao Immunotherapy AgTech Acute Radiation Osteoarthritis Cell-based Cultivated CDMO Technology Platform Coffee Cultivated Meat And beyond A collaborative network of companies Knowhow Validated Deep market Infrastructure GMP facility and expertise technology understanding and and corporat
Slide 9: A Clear Path to Venture Creation
A Clear Path to Venture Creation Feasibility & de-risking Model options Ventures Coffeesai 1. Ideation and market Company Creation assessment PluriCDMO 2. Partner collaboration for need validation Ever After Foods 3. Team recruitment Joint-Venture PROTO 4. POC Funding and validation 5. Corporate dev
Slide 10: Pluri Establishes a Collaborative Network of Ventures
Pluri Establishes a Collaborative Network of Ventures IP Improvements Registration of new patents and improvement of existing patents for various industries such as pharmaceuticals, food, and agriculture Shared Shared Facilities and Network Know-how of Partners Innovative GMP-certified Encouraging c
Slide 11: Joint Ventures
Joint Ventures
Slide 12: Growing the Future of Food with Cultivated Meat
Growing the Future of Food with Cultivated Meat Ever After Foods leverages Pluri’s cell expansion technology to produce mass scale, cost-effective food products in an efficient and sustainable manner, aiming to solve the industry’s scalability challenges Environmental Ethical Consumer ● Less land an
Slide 13: Ever After Foods Milestones
Ever After Foods Milestones • Tnuva $7.5 million according to a $40 million pre- money valuation • Pluri granted exclusive global royalty-bearing license to use its IP and expertise
Slide 14: Company Creation
Company Creation
Slide 15: Reimagining Coffee Without Ecological Cost
Reimagining Coffee Without Ecological Cost Climate Change Land Shortage decrease reduce Price Instability Carbon Footprint risen water
Slide 16: A Consistent Methodology for Rapid, De-risked Venture Creation
A Consistent Methodology for Rapid, De-risked Venture Creation
Slide 17: The Coffeesai Solution uses 100% Real Coffee
The Coffeesai Solution uses 100% Real Coffee Drying Roasting Brewing
Slide 18: Out Licensing
Out Licensing
Slide 19: PLX-R18 for Acute Radiation Syndrome
PLX-R18 for Acute Radiation Syndrome Ongoing studies and collaborations Survival Rate • Studies conducted and funded by Significant increase (68%) vs placebo U.S. government (NIH, DoD) (p<0.0001) • $4.2 Million contract signed with the US NIAID1 • Collaboration agreement with Hemafund to enhance Ukr
Slide 20: Pluri's Recent Achievements
Pluri’s Recent Achievements Collaborations €7.5M Consolidated Launch of cell- with global Collaboration cash balance based coffee agriculture with Charite $22M (as of business corps Berlin December 31, 2024) $10M strategic Launch of US Government Cultivated meat Coffeesai to Developing Launch of PRO
Slide 21: Science in Service of Humanity
Science in Service of Humanity Pluri is a global leader in cell technology, aiming to deliver cell-based solutions with a goal to improve global well-being and drive sustainability in multiple sectors
Slide 22: Our Collaborative Network of Partnerships
Our Collaborative Network of Partnerships Regulatory Scientific Collaborations Funding and Partnering
Slide 23: Our Team
Our Team Yaky Yanay Liat Zalts Lior Raviv Dr. Michal Sheleg, PhD Nimrod Bar Zvi CEO & President Chief Financial Officer Chief Technology Officer VP Clinical Development Chief Commercial Officer Dr. Arthur Machlenkin, PhD Efrat Livne-Hadass Orly Amiran Efrat Kaduri Chief Scientific Officer Chief Well
Slide 24: Thank You
THANK YOU. Our cell-based innovations are aimed at transforming industries with a goal to create a more sustainable, healthier world. From the food we eat to the medicine we consume, we are building solutions that can potentially serve humanity, one breakthrough at a time. For further info: investor